Cite

HARVARD Citation

    Gao, R. et al. (2021). YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO molecular medicine. 13 (12), p. n/a. [Online]. 
  
Back to record